EyeWorld Weekly, February 5, 2021
➤ 2021 ASCRS Annual Meeting update ➤ FDA approves new monofocal IOL ➤ First patient dosed in Phase 2 trial for investigational DED therapy ➤ Phase 2a trial initiated for add-on wet AMD therapy
Comments Off on EyeWorld Weekly, February 5, 2021
February 5, 2021